GeneDx Holdings (WGS) EBITDA

annual EBITDA:

-$1.26M+$135.20M(+99.08%)
December 31, 2024

Summary

  • As of today (May 29, 2025), WGS annual EBITDA is -$1.26 million, with the most recent change of +$135.20 million (+99.08%) on December 31, 2024.
  • During the last 3 years, WGS annual EBITDA has risen by +$219.49 million (+99.43%).
  • WGS annual EBITDA is now at all-time high.

Performance

1-year change

+99.08%

3-year change

+99.43%

5-year change

+94.4%

15-year change

+94.4%

WGS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

75.59%
WGS annual EBITDA is higher than 75.59% of companies in Healthcare sector

Range

All-time high

-$1.26M
WGS annual EBITDA is currently at an all-time high

3-year low

-$398.20M

Earnings dates

Last annual earnings report date

Dec 31, 2024
WGS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
WGS next annual earnings announcement has not yet been scheduled

OtherWGSincome statement metrics

Annual revenue

$305.45M
WGS annual revenue is $305.45 million

annual net income

-$52.29M
WGS annual net profit is -$52.29 million

annual EBIT

-$23.21M
WGS annual earnings before interest & taxes is -$23.21 million

Annual EPS

-$1.94
WGS annual earnings per share is -$1.94

quarterly EBITDA:

$236.00K-$14.13M(-98.36%)
March 31, 2025

Summary

  • As of today (May 29, 2025), WGS quarterly EBITDA is $236.00 thousand, with the most recent change of -$14.13 million (-98.36%) on March 31, 2025.
  • Over the past year, WGS quarterly EBITDA has increased by +$14.71 million (+101.63%).
  • WGS quarterly EBITDA is now -99.39% below its all-time high of $38.91 million, reached on September 1, 2021.

Performance

3-month change

-98.36%

1-year change

+101.63%

3-year change

+100.34%

5-year change

+100.42%

WGS quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

75.24%
WGS quarterly EBITDA is higher than 75.24% of companies in Healthcare sector

Range

All-time high

$38.91M
WGS quarterly EBITDA is currently -99.39% below its historical high of $38.91 million

3-year low

-$125.06M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
WGS previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 30, 2025
WGS next earnings announcement is scheduled for Jul 30, 2025

OtherWGSincome statement metrics

Quarterly revenue

$87.11M
WGS quarterly revenue is $87.11 million

quarterly net income

-$6.53M
WGS quarterly net profit is -$6.53 million

quarterly EBIT

-$5.44M
WGS quarterly earnings before interest & taxes is -$5.44 million

Quarterly EPS

-$0.23
WGS quarterly earnings per share is -$0.23

TTM EBITDA:

-$10.50M+$14.71M(+58.35%)
March 31, 2025

Summary

  • As of today (May 29, 2025), WGS TTM EBITDA is -$10.50 million, with the most recent change of +$14.71 million (+58.35%) on March 31, 2025.
  • Over the past year, WGS TTM EBITDA has increased by +$90.83 million (+89.64%).
  • WGS TTM EBITDA is now at all-time high.

Performance

3-month change

+58.35%

1-year change

+89.64%

3-year change

+89.99%

5-year change

+81.24%

WGS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

59.9%
WGS TTM EBITDA is higher than 59.9% of companies in Healthcare sector

Range

All-time high

-$10.50M
WGS TTM EBITDA is currently at an all-time high

3-year low

-$356.36M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
WGS previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 30, 2025
WGS next earnings announcement is scheduled for Jul 30, 2025

OtherWGSincome statement metrics

TTM revenue

$330.14M
WGS TTM revenue is $330.14 million

TTM net income

-$38.58M
WGS TTM net profit is -$38.58 million

TTM EBIT

-$32.88M
WGS TTM earnings before interest & taxes is -$32.88 million

TTM EPS

-$1.41
WGS TTM earnings per share is -$1.41

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$1.26M
WGS annual EBITDA is -$1.26 million

annual net income

-$52.29M
WGS annual net profit is -$52.29 million

annual interest expense

-
WGS annual interest expense value is unknown

annual income tax

-$343.00K
WGS annual income tax is -$343.00 thousand

annual D&A

$21.95M
WGS annual depreciation & amortization is $21.95 million

WGS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+99.1%+101.6%+89.6%
3 y3 years+99.4%+100.3%+90.0%
5 y5 years+94.4%+100.4%+81.2%

WGS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+99.7%-98.4%+100.2%at high+97.0%
5 y5-yearat high+99.7%-99.4%+100.1%at high+97.4%
alltimeall timeat high+99.7%-99.4%+100.1%at high+97.4%

WGS EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$236.00K(-98.4%)
-$10.50M(-58.3%)
Dec 2024
-$1.26M(-99.1%)
$14.36M(-876.0%)
-$25.21M(-57.4%)
Sep 2024
-
-$1.85M(-92.0%)
-$59.13M(-29.0%)
Jun 2024
-
-$23.25M(+60.6%)
-$83.29M(-17.8%)
Mar 2024
-
-$14.48M(-26.0%)
-$101.33M(-27.3%)
Dec 2023
-$136.46M(-65.7%)
-$19.55M(-24.8%)
-$139.32M(-30.5%)
Sep 2023
-
-$26.01M(-37.0%)
-$200.47M(-21.3%)
Jun 2023
-
-$41.29M(-21.3%)
-$254.77M(-24.7%)
Mar 2023
-
-$52.47M(-35.0%)
-$338.54M(-5.0%)
Dec 2022
-$398.20M
-$80.70M(+0.5%)
-$356.36M(+15.2%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$80.31M(-35.8%)
-$309.35M(+62.7%)
Jun 2022
-
-$125.06M(+77.9%)
-$190.13M(+81.3%)
Mar 2022
-
-$70.28M(+108.7%)
-$104.88M(-52.5%)
Dec 2021
-$220.75M(-2.8%)
-
-
Dec 2021
-
-$33.68M(-186.6%)
-$220.75M(-28.4%)
Sep 2021
-
$38.91M(-197.7%)
-$308.51M(-23.5%)
Jun 2021
-
-$39.82M(-78.6%)
-$403.40M(+11.0%)
Mar 2021
-
-$186.15M(+53.3%)
-$363.58M(+104.9%)
Dec 2020
-$227.13M(+908.8%)
-$121.45M(+117.0%)
-$177.43M(+217.0%)
Sep 2020
-
-$55.98M
-$55.98M
Dec 2019
-$22.51M
-
-

FAQ

  • What is GeneDx Holdings annual EBITDA?
  • What is the all time high annual EBITDA for GeneDx Holdings?
  • What is GeneDx Holdings annual EBITDA year-on-year change?
  • What is GeneDx Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for GeneDx Holdings?
  • What is GeneDx Holdings quarterly EBITDA year-on-year change?
  • What is GeneDx Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for GeneDx Holdings?
  • What is GeneDx Holdings TTM EBITDA year-on-year change?

What is GeneDx Holdings annual EBITDA?

The current annual EBITDA of WGS is -$1.26M

What is the all time high annual EBITDA for GeneDx Holdings?

GeneDx Holdings all-time high annual EBITDA is -$1.26M

What is GeneDx Holdings annual EBITDA year-on-year change?

Over the past year, WGS annual EBITDA has changed by +$135.20M (+99.08%)

What is GeneDx Holdings quarterly EBITDA?

The current quarterly EBITDA of WGS is $236.00K

What is the all time high quarterly EBITDA for GeneDx Holdings?

GeneDx Holdings all-time high quarterly EBITDA is $38.91M

What is GeneDx Holdings quarterly EBITDA year-on-year change?

Over the past year, WGS quarterly EBITDA has changed by +$14.71M (+101.63%)

What is GeneDx Holdings TTM EBITDA?

The current TTM EBITDA of WGS is -$10.50M

What is the all time high TTM EBITDA for GeneDx Holdings?

GeneDx Holdings all-time high TTM EBITDA is -$10.50M

What is GeneDx Holdings TTM EBITDA year-on-year change?

Over the past year, WGS TTM EBITDA has changed by +$90.83M (+89.64%)
On this page